Immuthera will continue expanding its Scientific Advisory Board over the coming months to build a truly world-class team. In collaboration with PolTREG and leading U.S. academic centers, Immuthera ...

Objective: There is a growing array of options for the treatment of immune-mediated inflammatory diseases (IMIDs). To explore upadacitinib’s efficacy and safety in autoimmune disease treatment, we ...

The Toll-like receptor (TLR) family comprises a class of proteins that play a critical role in the innate immune system. Toll-like receptors TLR7 and TLR8 are transmembrane receptors that recognize ...

Findings reveal an intricate mechanism that enables a careful treatment approach to T-cell driven autoimmune diseases.

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, multiple sclerosis, shows a new study in mice.

About Vor Bio Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases.

PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset & $175M Private Placement ...

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a bacterial disease that affects millions worldwide.